vCPP 2319

General Information


DRACP ID  DRACP01028

Peptide Name   vCPP 2319

Sequence  WRRRYRRWRRRRRWRRRPRR

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=5.02±1.04 µM CellTiter-Blue assay 24h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis>200µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01028

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C137H228N68O22

Absent amino acids  ACDEFGHIKLMNQSTV

Common amino acids  R

Mass  351877

Pl  13.31

Basic residues  15

Acidic residues  0

Hydrophobic residues  3

Net charge  15

Boman Index  -21695

Hydrophobicity  -365.5

Aliphatic Index  0

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  17990

Absorbance 280nm  946.84

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33015016

Title  To What Extent Do Fluorophores Bias the Biological Activity of Peptides? A Practical Approach Using Membrane-Active Peptides as Models

Doi 10.3389/fbioe.2020.552035

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.